Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2000
09/12/2000CA1341097C Factor viii binding domain of von willebrand factor
09/12/2000CA1341096C Cloning and use of the transaminase geme tyrb
09/12/2000CA1341095C Cdna coding for the human von willebrand factor, plasmids or phages with such a cdna coding or fragments thereof respectively, micro-organisms and animal or human cell which contain such plasmids or phages, preparation of proteins by the cultivation of the above mentioned hosts, the obtained proteins and pharmaceutical compositions containing a biologically
09/11/2000CA2276066A1 Microparticles for delivery of nucleic acid
09/08/2000WO2000052462A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities
09/08/2000WO2000052210A2 Methods for targeting rna molecules
09/08/2000WO2000052208A2 Customized oligonucleotide microchips that convert multiple genetic information to simple patterns
09/08/2000WO2000052206A1 Detection and quantification of micro-organisms using amplification and restriction enzyme analysis
09/08/2000WO2000052205A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE
09/08/2000WO2000052200A1 METHOD FOR LARGE SCALE cDNA CLONING AND SEQUENCING BY CIRCULATING SUBTRACTION
09/08/2000WO2000052193A1 METHOD FOR CONTROLLING CLEAVAGE BY OmpT PROTEASE
09/08/2000WO2000052192A1 Enzymatic dna molecules that contain modified nucleotides
09/08/2000WO2000052191A1 cDNA SYNTHESIS IMPROVEMENTS
09/08/2000WO2000052188A1 Packaging cells for retroviral vectors
09/08/2000WO2000052187A2 Enhanced system for construction of adenovirus vectors
09/08/2000WO2000052186A1 Means and methods for fibroblast-like or macrophage-like cell transduction
09/08/2000WO2000052185A1 Application of dna vectors for the treatment of viral infection
09/08/2000WO2000052184A1 Anti-neoplastic compositions and uses thereof
09/08/2000WO2000052183A1 Multigene expression vectors for the biosynthesis of products via multienzyme biological pathways
09/08/2000WO2000052182A1 Use of glutathione-s-transferase to increase stress tolerance in plants
09/08/2000WO2000052181A2 Gcn4-derived expression of heterologous coding sequences and different uses thereof
09/08/2000WO2000052180A1 Methods for generating and screening novel metabolic pathways
09/08/2000WO2000052179A2 Dna binding compound-mediated molecular switch system
09/08/2000WO2000052178A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
09/08/2000WO2000052177A1 Β-primeverosidase gene
09/08/2000WO2000052176A1 β-HEXOSAMINIDASE, DNA SEQUENCE FROM CILIATES FOR CODING THE SAME AND USE THEREOF
09/08/2000WO2000052175A1 Histidine protein-phosphatase
09/08/2000WO2000052174A1 Sakuranetin synthase gene
09/08/2000WO2000052173A2 Cloned human sphingosine kinase homologues
09/08/2000WO2000052172A1 Method of modifying plant morphology, biochemistry or physiology using cdc25 substrates
09/08/2000WO2000052171A1 Method of modifying plant morphology, biochemistry or physiology using cdc25
09/08/2000WO2000052170A1 PHENOL-INDUCED PROTEINS OF $i(THAUERA AROMATICA)
09/08/2000WO2000052169A1 Method of modifying plant morphology, biochemistry and physiology ii
09/08/2000WO2000052168A1 Method of selecting transformed cells and tissues
09/08/2000WO2000052167A1 Angiopoietin-related protein and nucleic acids
09/08/2000WO2000052166A1 Human suppressor of fused
09/08/2000WO2000052165A2 Compositions and methods for breast cancer therapy and diagnosis
09/08/2000WO2000052164A2 Potassium channel molecules and uses therefor
09/08/2000WO2000052163A1 Cloning of cdna of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer
09/08/2000WO2000052162A2 Eukaryotic peptide uptake system for transportation of enkephalins
09/08/2000WO2000052161A2 Leukocyte- and blood-associated proteins
09/08/2000WO2000052160A1 Human serpin proteins
09/08/2000WO2000052159A1 Methods and reagents for inhibiting proliferation of smooth muscle cells
09/08/2000WO2000052158A1 Methods and reagents for inhibiting angiogenesis
09/08/2000WO2000052157A1 Tumor-associated antigen
09/08/2000WO2000052156A1 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
09/08/2000WO2000052155A2 Recombination of insertion modified nucleic acids
09/08/2000WO2000052153A2 Method to identify ligands for orphan receptors
09/08/2000WO2000052152A1 Non-ribosomal peptide synthetases, method for producing same and the use thereof
09/08/2000WO2000052148A2 Substances for controlling fertility
09/08/2000WO2000052146A2 Encryption of traits using split gene sequences
09/08/2000WO2000052145A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
09/08/2000WO2000052144A1 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
09/08/2000WO2000052141A1 Cells resistant to toxic genes and uses thereof
09/08/2000WO2000052137A2 Plant ligand-gated ion channels
09/08/2000WO2000052135A2 Engineering intracellular sialylation pathways
09/08/2000WO2000052133A2 Hansenula polymorpha mutants and process for the preparation of recombinant proteins using the same
09/08/2000WO2000052056A2 Anti-plasmodium compositions and methods of use
09/08/2000WO2000052047A2 Human dickkopf-related protein and nucleic acid molecules and uses therefor
09/08/2000WO2000052044A1 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
09/08/2000WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b)
09/08/2000WO2000052027A1 Compositions and methods for use in recombinational cloning of nucleic acids
09/08/2000WO2000052022A1 Secreted proteins and nucleic acids encoding them
09/08/2000WO2000051621A1 Method for validating/invalidating target(s) and pathways
09/08/2000WO2000051432A1 Vaccines and gene therapy compositions and methods of making and using the same
09/08/2000WO2000051424A2 Genetic modification of somatic cells and uses thereof
09/08/2000WO2000051415A1 Improvements in the formation of brassica napus f1 hybrid seeds high oleic acid content and a reduced linolenic acid content
09/08/2000WO2000036116A3 Plant catabolite repression genes
09/08/2000WO2000036097A3 Methods for regulating vascularization using gef containing nek-like kinase (gnk)
09/08/2000WO2000034789A3 Method for determining asthma susceptibility
09/08/2000WO2000029583A3 Immunoglobulin superfamily proteins
09/08/2000WO2000026415A3 A method for genomic substractive hybridization
09/08/2000WO2000023592B1 Minimal promoters and uses thereof
09/08/2000WO2000023590A3 INHIBITION OF CD40-MEDIATED NFλB ACTIVATION
09/08/2000WO2000022139A9 Dna sequences for enzymatic synthesis of polyketide or heteropolyketide compounds
09/08/2000WO2000020622A9 Zinc finger peptide cleavage of nucleic acids
09/08/2000WO2000019883A3 Compositions and methods of disease diagnosis and therapy
09/08/2000WO2000018960A3 Methods and products related to genotyping and dna analysis
09/08/2000WO2000018940A9 Plants and plants cells encoding the wild type cop1 gene and the coil domain thereof
09/08/2000WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof
09/08/2000WO2000017377A3 Methods for large-scale production of recombinant aav vectors
09/08/2000WO2000015853A9 Recombinant newcastle disease virus rna expression systems and vaccines
09/08/2000WO2000014239A3 Thioredoxin h homologs
09/08/2000WO2000014205A9 Methods for generating high titer helper-free preparations of released recombinant aav vectors
09/08/2000WO2000013702A3 Use of an angiogenic factor for the treatment of microvascular angiopathies
09/08/2000WO2000013651A3 Luciferase reporter bioassay of parathyroid hormone compounds
09/08/2000WO2000012720A3 Elongase genes and uses thereof
09/08/2000WO2000012702A3 Human genes differentially expressed in colorectal cancer
09/08/2000WO2000012546A9 MAMMALIAN elk POTASSIUM CHANNEL GENES
09/08/2000WO2000011223A9 Use of pooled probes in genetic analysis
09/08/2000WO2000011144A3 Plastid-targeting nucleic acid sequence, beta-amylase sequence, a stimulus-responsive promoter and uses thereof
09/08/2000WO2000009709A3 Proteases and associated proteins
09/08/2000WO2000009697A3 Pesticidal toxins and genes from bacillus laterosporus strains
09/08/2000WO2000006755A3 Modification of starch biosynthetic enzyme gene expression to produce starches in grain crops
09/08/2000WO2000000604A9 Methods and compositions for modulating spermatogenesis
09/08/2000WO1999064595A9 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME
09/08/2000WO1999053961A9 Peptides for efficient gene transfer
09/08/2000WO1999049019A8 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
09/08/2000WO1999015650A9 Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna
09/08/2000CA2391612A1 Improvements in the formation of brassica napus f1 hybrid seeds with high oleic acid content and a reduced linolenic acid content
1 ... 3188 3189 3190 3191 3192 3193 3194 3195 3196 3197 3198 3199 3200 3201 3202 3203 3204 3205 3206 3207 3208 ... 4023